Gujarat Terce Laboratories Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 401.34 million compared to INR 251.78 million a year ago. Revenue was INR 404.4 million compared to INR 259.8 million a year ago. Net income was INR 8.72 million compared to net loss of INR 25.2 million a year ago. Basic earnings per share from continuing operations was INR 1.18. Diluted earnings per share from continuing operations was INR 1.18.